Treatment intensification does not improve outcomes beyond rituximab-based therapy in primary mediastinal B-cell lymphoma: a multicenter retrospective analysis.

Saved in:

Bibliographic Details
Title:	Treatment intensification does not improve outcomes beyond rituximab-based therapy in primary mediastinal B-cell lymphoma: a multicenter retrospective analysis.
Authors:	Herold, Stephanie¹ (AUTHOR) Stephanie.herold@unimedizin-mainz.de, Wieber, Charlotte² (AUTHOR), Acker, Fabian³ (AUTHOR), Liebers, Nora^4,5 (AUTHOR), Tilch, Marie-Kristin¹ (AUTHOR), Theobald, Matthias¹ (AUTHOR), Porubsky, Stefan⁶ (AUTHOR), Kreft, Andreas⁶ (AUTHOR), Ruckes, Christian⁷ (AUTHOR), Brunnberg, Uta³ (AUTHOR), Caille, Leandra⁵ (AUTHOR), Dietrich, Sascha⁴ (AUTHOR), Hess, Georg¹ (AUTHOR) Georg.hess@unimedizin-mainz.de
Source:	Leukemia & Lymphoma. Jun2026, p1-10. 10p. 2 Illustrations.
Database:	Academic Search Ultimate

Description
ISSN:	10428194
DOI:	10.1080/10428194.2026.2682281